Cancer Screening
Early Cancer Detection
Early cancer detection options for Canadians: detecting cancer before symptoms appear.
OVERVIEW
Many cancers develop silently.
Pancreatic cancer. Ovarian cancer. Certain types of lung cancer. By the time symptoms appear, the disease may already be advanced, making treatment more complex and outcomes less predictable.
This is why early cancer detection matters.
The goal is not to diagnose cancer outright, but to detect potential cancer signals early enough to guide timely investigation and, when necessary, earlier treatment.
For Canadians exploring early cancer detection options, advances in diagnostic technology are beginning to expand what is possible beyond standard screening programs.
At Kanata Health, we provide physician-guided access to advanced cancer screening technologies. We help patients understand whether these tools are appropriate and how to use them responsibly.
The Gap in Standard Care
Why Traditional Screening Is Limited
Standard cancer screening programs in Canada focus on a small number of cancers, including breast, cervical, and colorectal cancer.
These programs are essential, but they cover only part of the overall cancer landscape.
Approximately 70% of cancer deaths are caused by cancers that do not have routine population-level screening, including pancreatic, ovarian, liver, kidney, and several others.
For these cancers, the standard clinical pathway is often reactive. Patients develop symptoms, testing is performed, and treatment begins at whatever stage the cancer has reached.
This creates a fundamental gap: for many cancers, the opportunity for early detection is limited or does not exist within standard screening programs.
70%
of cancer deaths are caused by cancers with no routine population-level screening option.
Examples include
Pancreatic
Ovarian
Liver
Kidney
+ many others
New Diagnostic Technologies
Advances in multi-cancer early detection are beginning to address this gap.
These tests analyze fragments of DNA circulating in the bloodstream. Cancer cells release DNA into the blood, and these fragments can carry distinct biological signals.
These technologies have been evaluated in large clinical studies. The PATHFINDER study, which enrolled thousands of adults without a prior cancer diagnosis, demonstrated that multi-cancer early detection tests can identify signals across a wide range of cancers.
Notably, approximately two-thirds of the cancers identified in that study were types for which no standard screening currently exists.
These tests are not diagnostic. A positive result requires follow-up testing, and not all cancers produce detectable signals at early stages. Physician guidance is essential to ensure results are interpreted correctly.
Multi-cancer early detection tests are designed to
Detect signals associated with multiple cancer types from a single blood draw
Identify cancers that currently have no routine screening option
Provide information that helps guide targeted follow-up testing
Who It May Be For
Who Should Consider Early Cancer Detection
Early cancer detection testing may be appropriate if:
You want a more proactive approach to your health.
You are concerned about cancers that lack routine screening.
You have a family history of cancer.
You are already following standard screening guidelines and want additional insight.
You prefer earlier information rather than waiting for symptoms.
These tests are designed for adults who are not currently experiencing symptoms and want a broader understanding of their cancer risk. If you are experiencing symptoms that concern you, a different clinical pathway may be more appropriate. A consultation with Dr. Sanei can help determine the right approach for your situation, whether you have symptoms or not.
Not sure if early cancer detection testing is right for you?
A 30-minute consultation with Dr. Sanei will give you a clear answer based on your specific health picture.
Featured Test
Galleri® Multi-Cancer Early Detection Test
Galleri is a blood test designed to detect signals associated with more than 50 types of cancer from a single blood draw.
If a signal is detected, the test can also help predict where in the body it may be originating, guiding further diagnostic evaluation.
Galleri is not a diagnostic test. It is a screening tool designed to identify when further investigation may be appropriate.
Learn more about the Galleri test
Galleri® by GRAIL
Multi-Cancer Early Detection
Detects signals associated with more than 50 types of cancer from a single blood draw, including many with no current screening option.
50+
cancer types detectable from a single draw
~⅔
of detected cancers had no prior screening option (PATHFINDER)
Learn more about Galleri
Why Consultation Comes First
Why Consultation Comes First
A consultation with Dr. Sanei is the most important step in this process.
In a 30-minute virtual consultation, he reviews your medical history, family history of cancer, and overall risk profile to determine whether advanced cancer screening makes sense for you.
He explains what the test can and cannot tell you, what a positive result would mean, and what follow-up would look like.
Many patients find that this conversation alone, regardless of whether they proceed with testing, gives them the clarity they were looking for.
What to expect
01
Book a consultation
Virtual, 30 minutes, $150 CAD. No referral required.
02
Physician review
Dr. Sanei reviews your history, risk profile, and goals. He explains what the test can and cannot tell you before you decide.
03
Testing, if appropriate
For Galleri, a blood draw at a U.S. facility is required. Most patients in British Columbia can complete this as a same-day visit to Washington State.
04
Results review
Dr. Sanei reviews results with you and helps coordinate appropriate follow-up with your Canadian healthcare team.
FAQ
Frequently Asked Questions
Straight answers about early cancer detection, what these tests do, and whether they may be right for you.
Can I get a multi-cancer detection test without a doctor's referral in Canada?
What happens if my result shows a cancer signal?
What does a negative result mean?
Are these tests covered by provincial health plans in Canada?
Do these tests replace my regular cancer screening like mammograms or colonoscopies?
Do I need to travel to the United States for this test?
Book a Consultation
If you are looking for clearer answers, earlier insight, or a more personalized approach to your health, a consultation is the right place to start.